Search results
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 5 days agoPharma has announced that its injection treatment for atopic dermatitis, Adbry (tralokinumab-ldrm),...
Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines
FierceBiotech· 5 hours agoPreclinical models found that MAR001 reduced triglycerides, remnant cholesterol and ectopic fat,...
Missouri executes man convicted of killing former lover and her husband
FOX30 / CBS47 Jacksonville· 7 days agoDavid Hosier, 69, was pronounced dead at 6:11 p.m. following a single-dose injection of the sedative...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 19 hours agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Health Benefits of Prune Juice
Health via Yahoo News· 19 hours agoEvidence suggests drinking prune juice may help. An older study assessed the effects of prune and prune juice intake in 259 people with pre-hypertension...
FDA approves 1st adult vaccine for bacterial pneumonia
Becker’s Hospital Review· 9 hours ago"Merck receives FDA approval for Capvaxive, a new vaccine to protect adults from pneumococcus, a bacteria that can cause serious diseases like pneumonia."
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 5 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
Pressure on cholera vaccine stocks 'decreasing': Gavi alliance
AFP via Yahoo News· 10 hours agoA resurgence of cholera across Africa has driven an urgent need for more vaccine doses, but stock...
AI face-off: nerds vs. evangelists
Politico· 22 hours agoAdditionally, the bacteria that causes gonorrhea hasn’t shown any resistance to zoliflodacin, unlike the current therapy — potentially making the new...
Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study
Digital Journal· 3 hours agoWeight Loss and Blood Sugar Reduction are Major Efficacy Objectives KELOWNA, BC / ACCESSWIRE / June 18, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX,)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces
